If you have been reading about synthetic peptide and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-02-25. Where a claim depends on a specific study, the study is described rather than over-claimed.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form; visual inspection |
| Solubility | Soluble in water and aqueous buffers | Depends on pH, purity, and counterion |
| Typical storage | -20 °C or below, desiccated | Protect from light; avoid repeated freeze-thaw after reconstitution |
| Common analytical method | Reversed-phase HPLC and mass spectrometry | Purity by HPLC; identity and mass by LC-MS or MALDI-TOF |
| Common synonyms | hGH fragment 176–191; AOD-9604 | Names vary in research and product labeling |
Interest in AOD-9604 arose from attempts to separate metabolic effects from growth effects attributed to hGH. Early work explored whether the fragment could influence lipolysis or fat oxidation without promoting growth. Those questions remain partly unresolved because human data are limited and results have varied across studies. The peptide is not a hormone replacement for hGH and is not equivalent to hGH in clinical use. Its research history includes both laboratory studies and commercial marketing claims that are not the same as regulatory approval.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
=== Surgery === While the total mesorectal excision (TME) operation has become the surgical gold standard for the management of rectal cancer, this is not so for colon cancer. Recently, the surgical principles underpinning TME in rectal cancer have been extrapolated to colonic surgery. Total or complete mesocolic excision (CME), use planar surgery and extensive mesenterectomy (high tie) to minimise breach of the mesentery and maximise lymph nodes yield. Application of this T/CME reduces local five-year recurrence rates in colon cancer from 6.5% to 3.6%, while cancer-related five-year survival rates in patients resected for cure increased from 82.1% to 89.1%.
Synephrine, under the developmental code name AB-102 and acting as a weak α1-adrenergic receptor agonist, is or was under development for the treatment of alopecia (hair loss) via topical administration. It has been found to cause contraction of arrector pili muscles (hair erector muscles), thereby increasing the force required to pluck hair and reducing hair shedding during brushing. It was originated by Applied Biology and is being developed by Safety Shot. As of February 2024, either no recent development has been reported or development has been discontinued. The drug has reached phase 1 clinical trials. Besides synephrine alone, a topical combination of phenylephrine, synephrine, and tyramine, with the code name DA-007, is also under formal development for the treatment of alopecia.
If the content of a single indispensable amino acid in the diet is less than the individual's requirement, then it will limit the utilization of other amino acids and thus prevent the normal rates of synthesis even when the total nitrogen intake level is adequate. Thus the "limiting amino acid" will determine the nutritional value of the total nitrogen or protein in the diet. Protein sources, including plants, are thus rated by their limiting amino acids. In any diet, it is critical to consume enough of each essential amino acid. While this is very easy in any diet which consumes meat, a plant-based diet may theoretically miss out on one or more of the essential amino acids, consuming them only in very small quantities. However, in practice, the vast majority of satisfying vegan diets contain more than enough variety in their component foods to meet the minimum requirements of all essential amino acids.
At the third AU summit, held in Tripoli, Libya, in July 2005, Gaddafi called for greater integration, advocating a single AU passport, a common defence system, and a single currency, using the slogan: "The United States of Africa is the hope." His proposal for a Union of African States, a project originally conceived by Ghana's Kwame Nkrumah in the 1960s, was rejected at the 2001 Assembly of Heads of States and Government (AHSG) summit in Lusaka by African leaders who thought it "unrealistic" and "utopian". In June 2005, Libya joined the Common Market for Eastern and Southern Africa (COMESA). In March 2008 in Uganda, Gaddafi gave a speech once again urging Africa to reject foreign aid. In August 2008, Gaddafi was proclaimed "King of Kings" by a committee of traditional African leaders; they crowned him in February 2009, in a ceremony held in Addis Ababa, Ethiopia. That same month, Gaddafi was elected as the chairperson of the African Union, a position he retained for one year. In October 2010, Gaddafi apologized to African leaders for the historical enslavement of Africans by the Arab slave trade.
Sources: en.wikipedia.org
During Bukele's September 2019 meeting with Trump, Bukele called on Trump to promote legal migration in an effort to combat illegal immigration and to maintain the United States' temporary protected status (TPS) policy for Salvadorans living in the United States. The following month, Bukele confirmed that the United States would continue TPS for Salvadorans. In February 2021, Biden refused to meet Bukele when he arrived unannounced in Washington, D.C. to meet him. Bukele did not attend the 9th Summit of the Americas in June 2022 due to frustration with the U.S. government's allegations of corruption and human rights abuses by his government. Some Democratic Party members have been critical of Bukele's government, and members of the Republican Party have supported him and his policies. Bukele and Norma Torres, a member of the U.S. Congress representing California's 35th congressional district, engaged in an April 2021 argument on Twitter about illegal immigration at the United States' southern border. Torres accused Bukele in November 2022 of interfering in that month's 35th congressional district election by endorsing Republican challenger Mike Cargile. In January 2024, fourteen Democratic members of Congress sent a letter to Biden about Bukele's "authoritarian" actions. Meanwhile, Republican congressmen such as Tom Cotton, Matt Gaetz, and Marco Rubio have praised Bukele's policies on crime. The second Trump administration considers Bukele to be an important ally in mitigating immigration to the U.S. from Central America.
Lee Limbird (born November 27, 1948, in Philadelphia, Pennsylvania) is a pharmacologist, Dean of the School of Natural Science, Mathematics and Business & Professor in the Department of Life and Physical Sciences at Fisk University, Nashville, Tennessee. Limbird has been recognized for "outstanding scientific contributions in research and mentoring in pharmacology", in particular her "pioneering research on alpha-2 adrenergic receptors and how they relate to the regulation of blood pressure, sedation, pain suppression and opioid drug action". Among other awards, she received the Julius Axelrod Award from the American Society for Pharmacology and Experimental Therapeutics (ASPET) in 2013.
== Activity == Given its half-life, the radioactive activity of a gram of 60Co is close to 42 TBq (1,100 Ci). The absorbed dose constant, used in calculations of gamma-ray exposure, is related to the decay energy and time. For 60Co it is equal to 0.35 mSv/(GBq h) at one meter from the source. This allows calculation of the equivalent dose, which depends on distance and activity - for example, 2.8 GBq or 60 μg of 60Co, generates a dose of 1 mSv at 1 meter away, within an hour. Test sources, such as those used for school experiments, have an activity of <100 kBq. Devices for nondestructive material testing use sources with activities of 1 TBq and more. The decay energy of cobalt-60 amounts to about 26 watts per gram, about 40 times larger (by mass) than that of e.g. 238Pu but still not very significant for practical sources.
Following ISIL's successful Anbar campaign and June 2014 offensive, the Badr Organization mobilized and won a series of battles against ISIL, including the Liberation of Jurf Al Sakhr and the Lifting of the Siege of Amirli. In early February 2015, the group, operating from its base at Camp Ashraf, fought in Diyala Governorate against ISIL. Over 100 militia were killed in the fighting, including 25 in Al Mansouryah. Badr's leader, Hadi al-Amiri, said his militiamen were committed to the safety of Sunnis, but deep mutual suspicions remained in the light of recent sectarian killings and the suspicion that some Sunni tribes were allied with IS. A leaked US diplomatic cable cited sources alleging that Hadi al-Amiri had personally ordered attacks on Sunnis.
=== Since 1994 === A new interim constitution, introduced in 1994 after four years of negotiation, finally introduced all-race democracy and enfranchised men and women of all races on equal terms, the minimum age remaining 18 years. Parliament was reconstituted to consist of a Senate and a National Assembly.
Sources: en.wikipedia.org
Lyophilized AOD9604 is generally kept at -20 °C or colder, desiccated, and protected from light. Reconstituted solutions are usually refrigerated and handled to minimize repeated freeze-thaw cycles. These are general laboratory handling practices, not instructions for human use.
Mass spectrometry, such as LC-MS or MALDI-TOF, confirms the molecular mass and can reveal sequence-related impurities. Reversed-phase HPLC is used for purity, and peptide mapping or amino acid analysis can support sequence identity. No single method establishes every quality attribute.
No. AOD9604 is a short synthetic fragment of the hGH sequence, not the full 191-amino-acid hormone. It lacks the regions that mediate hGH receptor activation and growth-promoting effects. Products labeled as AOD9604 should not be assumed to have the same properties as hGH.
Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.